image
Healthcare - Biotechnology - NASDAQ - US
$ 0.68
8.59 %
$ 3.94 M
Market Cap
-0.11
P/E
BALANCE SHEET
18.1 M ASSETS
-69.97%
10.8 M LIABILITIES
4.09%
7.28 M EQUITY
-85.40%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Hepion Pharmaceuticals, Inc.
image
Current Assets 17.5 M
Cash & Short-Term Investments 14.8 M
Receivables 0
Other Current Assets 2.7 M
Non-Current Assets 607 K
Long-Term Investments 0
PP&E 242 K
Other Non-Current Assets 364 K
Current Liabilities 5.29 M
Accounts Payable 2.35 M
Short-Term Debt 232 K
Other Current Liabilities 2.71 M
Non-Current Liabilities 5.52 M
Long-Term Debt 93.1 K
Other Non-Current Liabilities 5.43 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Jun-2017 Jun-2016 Jun-2015 Jun-2014 Jun-2013
ASSETS
Cash & Cash Equivalents 14.8 51.2 91.3 40.7 13.9 2.8 6.0 13.0 7.4 4.6 1.8 86.7 K
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 2.7 5.3 6.1 1.9 0.5 0.1 0.1 0.2 0.5 0.7 0.2 0
Total Current Assets 17.5 56.5 97.5 42.6 14.4 3.0 6.1 13.2 7.9 5.2 2.0 86.7 K
PP&E 0.2 0.1 0.5 0.7 0.9 32.4 K 56.6 K 67.6 K 80.8 K 81.4 K 14.5 K 0
Intangible Assets 0 3.2 3.2 3.2 3.2 3.2 0 3.2 3.2 0 0 0
Goodwill 0 0 1.9 1.9 1.9 1.9 1.9 1.9 1.9 0 0 0
Long Term Investments 0 (0.6) (0.6) (0.7) 0 0 0 0 0 0 0 0
Other Long Term Assets 0.4 0.4 0.6 0.3 0.3 0.1 3.3 63.2 K 70 K 51.3 K 4.2 K 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 18.1 60.2 103.6 48.6 20.6 8.2 11.3 18.4 13.1 5.4 2.0 86.7 K
LIABILITIES
Accounts Payable 2.3 2.7 2.4 3.7 0.5 0.7 1.6 1.6 4.3 1.5 0.2 3.62 K
Short Term Debt 0.2 0.1 0.5 0.6 0.5 1.4 0 0 10.4 K 0 0 0.1
Other Current Liabilities 2.7 5.1 5.2 0.3 0.2 0.7 1.0 1.3 0.8 0.5 0.2 0.1
Total Current Liabilities 5.3 7.9 8.2 4.7 1.6 2.8 2.6 2.9 5.1 1.9 0.5 0.2
Long Term Debt 93.1 K 0 50.3 K 0.5 0.5 0 0 0 0 0 0 0
Deferred Tax Income 0 0.4 0.4 0.4 0.4 0.4 0.9 1.3 1.3 0 0 0
Other Liabilities 5.4 2.1 1.9 2.6 2.4 3.0 4.0 5.1 5.4 0 4.5 0
Total Liabilities 10.8 10.4 10.6 8.1 5.0 6.2 7.5 9.3 11.8 1.9 4.9 0.2
EQUITY
Common Stock 482 7.62 K 7.62 K 3.2 K 375 25 7.83 K 7.57 K 3.22 K 2.23 K 1.85 K 900
Retained Earnings (224.6) (175.7) (133.5) (104.1) (83.8) (76.5) (67.0) (59.5) (44.6) (27.6) (5.4) (0.1)
Other Accumulative Comprehensive Income/Loss 78.8 K 90.2 K 0 0 0 0 0 0 0 0 0 900
Total Equity 7.3 49.9 93.0 40.5 15.6 2.0 3.7 9.1 1.3 3.4 (2.9) (0.1)
Total Liabilities and Equity 18.1 60.2 103.6 48.6 20.6 8.2 11.3 18.4 13.1 5.4 2.0 86.7 K
SHARES OUTSTANDING
Common Shares Outstanding 4.0 3.8 3.5 0.5 0.1 9.19 K 6.91 K 5.2 K 2.42 K 1.94 K 1.14 K 33 K